Sigurdur O Olafsson
CIK 1499481 · President and CEO · last filed 2026-02-26
Sigurdur O Olafsson is a President and CEO who has filed 28 SEC Form 4 insider transactions across 4 companies since 2010. Across all open-market trades the lifetime net is +$25.1K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
28
$25.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Keenova Therapeutics plc (MNK) Delisted | President and CEO | 189,863 | $0.34 | $64.6K | $25.1K | 4 | 2023-06-26 |
| Pfenex Inc. (PFNX) Delisted | Director | — | — | — | $0 | 3 | 2019-05-10 |
| ACT | Pres.-Global Generics | 0 | $42.41 | $0 | $0 | 1 | 2013-10-02 |
| Actavis, Inc. (WPI) Delisted | Pres-Global Generics | 68,163 | — | — | $0 | 5 | 2012-11-02 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-26 | — | Grant (A) | — | $0 | |
| 2026-01-05 | — | Mixed | +15,939 | $0 | |
| 2025-08-18 | — | Grant (A) | — | $0 | |
| 2025-08-04 | — | Grant (A) | — | $0 | |
| 2025-01-17 | — | Tax (F) | −11,576 | $0 | |
| 2025-01-02 | — | Mixed | +15,775 | $0 | |
| 2024-02-06 | — | Grant (A) | — | $0 | |
| 2023-11-16 | — | Disp (D) | −189,863 | $0 | |
| 2023-06-26 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −38,409 | -$50.3K | EDGAR |
| 2023-04-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |